MXPA03003236A - Composicion y metodo para liquidos inyectables estables. - Google Patents

Composicion y metodo para liquidos inyectables estables.

Info

Publication number
MXPA03003236A
MXPA03003236A MXPA03003236A MXPA03003236A MXPA03003236A MX PA03003236 A MXPA03003236 A MX PA03003236A MX PA03003236 A MXPA03003236 A MX PA03003236A MX PA03003236 A MXPA03003236 A MX PA03003236A MX PA03003236 A MXPA03003236 A MX PA03003236A
Authority
MX
Mexico
Prior art keywords
component
further characterized
glass
percent
composition
Prior art date
Application number
MXPA03003236A
Other languages
English (en)
Spanish (es)
Inventor
James Maki
Original Assignee
Cambridge Biostability Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd filed Critical Cambridge Biostability Ltd
Publication of MXPA03003236A publication Critical patent/MXPA03003236A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA03003236A 2000-10-13 2000-10-13 Composicion y metodo para liquidos inyectables estables. MXPA03003236A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Publications (1)

Publication Number Publication Date
MXPA03003236A true MXPA03003236A (es) 2004-12-03

Family

ID=21741883

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003236A MXPA03003236A (es) 2000-10-13 2000-10-13 Composicion y metodo para liquidos inyectables estables.

Country Status (12)

Country Link
EP (1) EP1328255A1 (zh)
JP (1) JP2004513093A (zh)
KR (1) KR20030096224A (zh)
CN (1) CN100339066C (zh)
AU (2) AU2001211986B2 (zh)
CA (2) CA2424656C (zh)
ES (1) ES2337252T3 (zh)
MX (1) MXPA03003236A (zh)
NO (1) NO20031706D0 (zh)
PL (1) PL360052A1 (zh)
PT (1) PT1452171E (zh)
WO (1) WO2002032402A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502825A1 (en) * 2002-10-22 2004-05-06 Dainippon Pharmaceutical Co., Ltd. Stabilized composition
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
JP2007532619A (ja) 2004-04-13 2007-11-15 ケンブリッジ バイオスタビリティ リミテッド 懸濁したガラス粒子を含有する液体
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
MX2010007632A (es) * 2008-01-18 2010-08-03 Asahi Kasei Pharma Corp Composicion farmaceutica estable.
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (en) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension of particles with drug
WO2011007327A2 (en) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension for therapeutic use and device for delivering said suspension
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
EP3124275A4 (en) 2014-03-24 2018-03-14 Seiko Epson Corporation Tape printing device and tape printing system
CN106102724A (zh) * 2014-03-27 2016-11-09 诺华股份有限公司 用于吸入活性药物成分的经喷雾干燥的水包油包固体分散系

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (zh) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Also Published As

Publication number Publication date
PT1452171E (pt) 2010-03-08
EP1328255A1 (en) 2003-07-23
CN1527699A (zh) 2004-09-08
NO20031706L (no) 2003-04-11
AU1198601A (en) 2002-04-29
CA2424656A1 (en) 2002-04-25
NO20031706D0 (no) 2003-04-11
CA2689856C (en) 2013-09-24
WO2002032402A1 (en) 2002-04-25
ES2337252T3 (es) 2010-04-22
CA2424656C (en) 2010-03-23
PL360052A1 (en) 2004-09-06
KR20030096224A (ko) 2003-12-24
JP2004513093A (ja) 2004-04-30
CN100339066C (zh) 2007-09-26
AU2001211986B2 (en) 2007-04-26
CA2689856A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
US6190701B1 (en) Composition and method for stable injectable liquids
CA2424656C (en) Composition and method for stable injectable liquids
Parumasivam et al. Dry powder inhalable formulations for anti-tubercular therapy
AU2001211986A1 (en) Composition and method for stable injectable liquids
EA001873B1 (ru) Стабильная частица в жидких композициях
EP1750668B1 (en) Liquids containing suspended glass particles
US20110045079A1 (en) Dry powders of cellular material
WO2000000215A1 (en) Particulate delivery systems and methods of use
JP2008510686A (ja) 神経ガス中和酵素の肺送達
KR102624471B1 (ko) 가스 충전된 미세소포
KR20030020294A (ko) 분말 조성물
US20010055610A1 (en) Medicament administration system
WO2004073735A1 (en) Improved anthrax vaccines and delivery methods
AU2005203369B2 (en) Pharmaceutical liquid suspensions
EP1452171B1 (en) Pharmaceutical liquid suspensions
AU760537C (en) Particulate delivery systems and methods of use
JP4027881B2 (ja) 安定注射液用の組成物および方法
JP4382706B2 (ja) 医薬液体懸濁物
KR100743442B1 (ko) 약제적 액체 현탁액
RU2259817C2 (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
NZ525026A (en) A two-component composition comprising particles of sugar glass and a biocompatible liquid perfluorocarbon
NZ538681A (en) A pharmaceutical composition comprising active biological ingredient carried by particles that form a stable suspension in a liquid indefinitely
CN100594937C (zh) 稳定的注射液组合物和方法
RU2003113537A (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки

Legal Events

Date Code Title Description
FG Grant or registration